Rosuvastatin 40mg tablets recalled nationwide for manufacturing process deviations
RemedyRepack is voluntarily recalling Rosuvastatin 40mg tablets due to manufacturing practice deviations. The recall affects specific lot numbers expiring 07/31/2025 distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported adverse events or illnesses. This is a voluntary precautionary recall due to manufacturing practice deviations (cGMP violations), matching Moderate severity criteria.
Plain-English summary
RemedyRepack Inc. is recalling Rosuvastatin 40mg tablets nationwide due to deviations in current Good Manufacturing Practice (cGMP) in the repackaging process. The firm voluntarily initiated this recall on March 20, 2023, and the recall was terminated on October 19, 2023.
The affected product was packaged in 45-count bottles (NDC 70518-1311-01) with lot numbers B2038806-123022, B2014185-121422, and B1925528-102522, and in 90-count bottles (NDC 70518-0484-00) with lot numbers B2080829-012823, B1938007-110222, and B2038746-123022. All affected product expires on 07/31/2025. A total of 76 of the 45-count bottles and 151 of the 90-count bottles are subject to recall.
The product was distributed to consignees nationwide within the United States. The recall number is D-0502-2023.
The recalled product
- Product
- Rosuvastatin 40mg tablets, packaged in a) 45-count bottles (NDC 70518-1311-01), and b) 90-count bottles (NDC 70518-0484-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.
- Manufacturer
- RemedyRepack Inc.
- Category
- Drug
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot # a): B2038806-123022
- B2014185-121422
- B1925528-102522
- Exp. Date 07/31/2025. Lot #: b): B2080829-012823
- B1938007-110222
- B2038746-123022
- Exp. Date 07/31/2025.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27